![](https://img.einnews.com/small/701802/erythropoietin-market-2024.jpeg)
Erythropoietin Drugs Market to Reach $14.41 Bn by 2032, Fueled by 5.7% CAGR: Johnson & Johnson, Amgen, Roche, Hospira
PORTLAND, OREGON, UNITED STATES, July 8, 2024 /EINPresswire.com/ -- Rise in prevalence of cancer, HIV, anemia, and kidney diseases, surge in level of awareness about the benefits of EPO therapeutics, and commercialization for erythropoietin …